RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Ensysce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:34 pm Sale | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -98,400 (Position Closed) | Filing |
| 2024-11-06 4:15 pm Purchase | 2024-10-30 | 13G | Ensysce Biosciences, Inc. ENSC | RA CAPITAL MANAGEMENT L.P. | 98,400 9.900% | 98,400 (New Position) | Filing |